1 Mayatepek E, Hoffmann B, Meissner T. Inborn errorsof carbohydrate metabolism[J]. Best Pract Res ClinGastroenterol, 2010, 24:607-618.2 Rake JP, Visser G, Labrune P, et al. Glycogen storagedisease type I:diagnosis, management, clinical courseand outcome. Results of the European Study onGlycogen Storage Disease Type I (ESGSD I)[J]. Eur JPediatr, 2002, 161(Suppl 1):S20-34.3 Smit GP. The long-term outcome of patients withglycogen storage disease type Ia[J]. Eur J Pediatr,1993, 152(Suppl 1):S52-55.4 郭立琳, 徐瑞燚, 朱文玲. 糖原累积症Ⅰ型心血管受累的临床分析[J]. 中华心血管病杂志, 2011, 39:508-514.5 Meschia JF, Bushnell C, Boden-Albala B, et al.Guidelines for the Primary Prevention of Stroke:AStatement for Healthcare Professionals From theAmer ican Hear t Association /Amer ican St rokeAssociation[J]. Stroke, 2014, 45:3754-3832.6 Fine RN, Podosin R, Donnell GN. Acute hemiplegiain glycogen storage disease type 1[J]. Acta PaediatrScand, 1969, 58:621-624.7 Aydinli N, Tatli B, Caliskan M, et al. Stroke inchildhood:experience in Istanbul, Turkey[J]. J TropPediatr, 2006, 52:158-162.8 Goulart JM, Yoo JY, Kirchoff-Torres KF, et al.Ischemic stroke in an adult with glycogen storagedisease type I[J]. J Clin Neurosci, 2010, 17:1467-1469.9 Berzsenyi MD, Brady BM, O’Donnell CJ, et al.Cerebrovascular disease in type 1A glycogen storagedisease[J]. J Clin Neurosci, 1998, 5:93-94.10 Sunder TR. Moyamoya disease in a patient with type Iglycogenosis[J]. Arch Neurol, 1981, 38:251-253.11 Egashira Y, Takahashi JC, Ohnishi H, et al. Surgicalt reatment and per ioperat ive management ofmoyamoya disease associated with glycogen storagedisease Type 1a[J]. J Neurosur-gery, Pediatrics, 2011,7:11-14.12 Goutières F, Bourgeois M, Trioche P, et al. Moyamoyadisease in a child with glycogen storage disease typeIa[J]. Neuropediatrics, 1997, 28:133-134.13 Weiss C, Witt TN, Fesl G, et al. Angiographicmoyamoya in a female with glycogenosis type IA-acase report focusing therapeutic management:bilateralencephalo-duro-arterio-myo-synangiosis(EDAMS)[J].Fortschr Neurol Psychiatr, 2010, 78:154-160.14 Austin SL, EI-Gharbawy AH, Kasturi VG, et al.Menorrhagia in patients with type I glycogen storagedisease[J]. Obstet Gynecol, 2013, 122:1246-1254.15 Pi z zo CJ. Ty pe I g lycogen storage d i seasewith focal nodular hyperplasia of the liver andvasoconst r ict ive pulmonary hyper tension[J ].Pediatrics, 1980, 65:341-343.16 Talente GM, Coleman RA, Alter C, et al. Glycogenstorage disease in adults[J]. Ann Intern Med, 1994,120:218-226.17 Smit GP, Fernandes J, Leonard JV, et al. The longtermoutcome of patients with glycogen storagediseases[J]. J Inherit Metab Dis, 1990, 13:411-418.18 Kishnani PS, Austin SL, Arn P, et al. Glycogenstorage disease type III diagnosis and managementguidelines[J]. Genet Med, 2010, 12:446-463.19 Carvalho PM, Silva NJ, Dias PG, et al. GlycogenStorage Disease type 1a - a secondary cause forhyperlipidemia:report of five cases[J]. J DiabetesMetab Disord, 2013, 12:25.20 Fernández -Friera L, Ibanez B and Fuster V. Imagingsubclinical atherosclerosis:is it ready for prime time?A review[J]. J Cardiovasc Transl Res, 2014, 7:623-634.21 Yekeler E, Dursun M, Emeksiz E, et al. Prediction ofpremature atherosclerosis by endothelial dysfunctionand increased intima-media thickness in glycogenstorage disease types Ia and Ⅲ[J]. Turk J Pediatr,2007, 49:115-119.22 Bernier AV, Correia CE, Haller MJ, et al. VascularDysfunction in Glycogen Storage Disease Type I[J]. JPediatr, 2009, 154:588-591.23 Lee PJ, Celermajer DS, Robinson J, et al. Hyperlipidaemiadoes not impair vascular endothelial function inglycogen storage disease type 1a[J]. Atherosclerosis,1994, 110:95-100.24 Ubels FL, Rake JP, Slaets JP, et al. Is glycogen storagedisease 1a associated with atherosclerosis?[J]. Eur JPediatr, 2002, 161(Suppl 1):S62-64.25 Fathi R, Marwick TH. Noninvasive tests of vascularfunction and structure:why and how to performthem[J]. Am Heart J, 2001, 141:694-703.26 Wittenstein B, Klein M, Finckh B, et al. Radicaltrapping in glycogen storage disease 1a[J]. Eur JPediatr, 2002, 161(Suppl 1):S70-74.27 Koren E, Lipkin J, Klar A, et al. Total oxidantscavengingcapacities of plasma from glycogenstorage disease type Ia patients as measured by cyclicvoltammetry, FRAP and luminescence techniques[J].J Inherit Metab Dis, 2009, 32:651-659.28 Kalkan US, Coker M, Sozmen E, et al. A monocentricpilot study of an antioxidative defense and hsCRPin pediatric patients with glycogen storage diseasetype IA and Ⅲ[J]. Nutr Metab Cardiovasc Dis, 2009,19:383-390.29 Muhlhausen C, Schneppenheim R, Budde U, et al.Decreased plasma concentration of von Willebrandfactor antigen (VWF:Ag) in patients with glycogenstorage disease type Ia[J]. J Inherit Metab Dis, 2005,28:945-950.30 Marfaing-Koka A, Wolf M, Boyer NC, et al. Increasedlevels of hemostatic proteins are independent ofinflammation in glycogen storage disease type Ia[J]. JPediatr Gastroenterol Nutr, 2003, 37:566-570.31 Rosenson RS, Brewer HB Jr, Davidson WS, et al.Cholesterol efflux and atheroprotection:advancingthe concept of reverse cholesterol transport[J].Circulation, 2012, 125:1905-1919.32 Prosser HC, Ng MK, Bursill CA. The role of cholesterolefflux in mechanisms of endothelial protection byHDL[J]. Curr Opin Lipidol, 2012, 23:182-189.33 Andrew DN, Chi-Jiunn P, Jeng-Jer S, et al. Increasedcellular cholesterol efflux in glycogen storage diseasetype Ia:A potential mechanism that protects againstpremature atherosclerosis[J]. FEBS Lett, 2005,579:4713-4718.34 Nguyen AD, Pan CJ, Weinstein DA, et al. Increasedscavenger receptor class B type I-mediated cellularcholesterol efflux and antioxidant capacity in the seraof glycogen storage disease type Ia patients[J]. MolGenet Meta, 2006, 89:233-238.35 Tamaki M, Tamura Y, Ogihara T, et al. Lack of evidentatherosclerosis despite multiple risk factors in glycogenstorage disease type 1a with hyperadiponectinemia[J].Metabolism, 2007, 56:1402-1404. |